DAOIB

N/A

Report date: 2023/01/01 08:31:35

Base Information

Drug NameDAOIB
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsPost-Acute COVID-19 SyndromeTranscranial Direct Current StimulationCognitive Dysfunction +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesChang Gung Memorial Hospital
China Registration ClassN/A

Develop Information

Active CompaniesChang Gung Memorial Hospital
Inactive CompaniesN/A
Active IndicationsPost-Acute COVID-19 SyndromeTranscranial Direct Current StimulationCognitive Dysfunction +[5] 
Inactive IndicationsDementia, Vascular

Other Information

ATC CodeN/A
Related LinksN/A